Porter Ranch, CA, United States of America

Marco Sillus

This inventor holds 1 USPTO granted patent. Top assignee: Medtronic Minimed, Inc.. Active years: 2013.


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marco Sillus: Innovator in Crosslinking Compounds

Introduction

Marco Sillus is a notable inventor based in Porter Ranch, CA (US). He has made significant contributions to the field of materials science, particularly in the development of crosslinking compounds. His work has implications for medical technology, especially in diabetes management.

Latest Patents

Marco Sillus holds 1 patent for his invention titled "Crosslinking compounds at negative pressures and materials made by such methods." This patent outlines methods for crosslinking various compounds, resulting in materials that include glucose sensors. These sensors play a crucial role in the management of diabetes, showcasing the practical applications of his innovative work.

Career Highlights

Marco is currently employed at Medtronic Minimed, Inc., a leading company in diabetes management technology. His role at Medtronic allows him to apply his expertise in crosslinking compounds to develop advanced medical devices that improve patient care.

Collaborations

Throughout his career, Marco has collaborated with talented professionals such as Gil Bruso and Rajiv Shah. These collaborations have fostered an environment of innovation and have contributed to the success of his projects.

Conclusion

Marco Sillus is a dedicated inventor whose work in crosslinking compounds has the potential to significantly impact diabetes management. His contributions to Medtronic Minimed, Inc. and his collaborations with other professionals highlight his commitment to advancing medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…